BMS-986260
selective TGFβR1 kinase inhibitor completed oral CV studies in higher species from data mining of internal matter and opt. ACS Med. Chem. Lett. 11, 172-178 Bristol-Myers Squibb, Princeton, NJ
Molecules of the Month - February 2020
Molecules of the Month
- LNP023
- LMB763 (nidufexor)
- ABBV-744
- AG-881
- FT-2102 (olutasidenib)
- GS-9876 (lanraplenib)
- "compound 25"
- "compound 25"-2
- WF-47-JS03
- BMS-986260
- GNF2133